Fixed or weight-adjusted dose in immunotherapy?
Our study showed a percentage of overdose of all drugs when using a fixed-dose regimen. This translates into a considerable increase in the budgetary impact versus the weight-adjusted dosing. The survey shows the scenario of our healthcare practice at the national level, confirming the variability in dosage regimens used in Spanish hospitals and the possible budgetary impact that therapeutic optimisation would entail.
Authors
- Ana Valladolid-Walsh
- M Díaz-Rangel
- Ana Cristina Cercós-Lletí
- Francisca Sanchez-Rubio
- Andrea Drozdz-Vergara
- Juan Manuel Collado-Sanz
- Sonia Ruiz-Sanchez
Institutions
- Hospital General de Almansa (ES)
- Hospital Universitario Doctor Peset (ES)
- Hospital General Universitario de Albacete (ES)
Publication Details
- Journal
- European Journal of Hospital Pharmacy
- Published
- 2024-12-18
- DOI
- https://doi.org/10.1136/ejhpharm-2024-004324
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00